March 3, 2026
UroGen lands $250M despite $153M loss — Are lenders right to bet on bladder cancer’s next blockbuster?
BioPharma Credit gets a bigger slice — and a $3M fee — as UroGen bets big on ZUSDURI
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Mitomycin
March 20, 2018
Mylan launches Mitomycin, generic cancer drug version of BMS’s Mutamycin
Mylan N.V. has launched its generic version of BMSs oncology drug Mutamycin in USA, called Mitomycin, for which it noted…